Concepedia

A phase III, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of antegren (Natalizumab) in maintaining clinical response and remission in Crohn’s disease (ENACT-2)

William J. Sandborn, J F Colombel, R A Enns, Brian G. Feagan, Stephen B. Hanauer, Ian C. Lawrance, Remo Panaccione, M. Sanders, Stefan Schreiber, Ş. Targan,

Gastroenterology · 2004 · 24 citations · 0 references

Open access

Concepts

PharmacyImmunologyPharmacotherapyGastrointestinal PharmacotherapyImmunotherapyInflammationAnti-inflammatory PharmacologyChronic InflammationCrohn Disease PharmacotherapyGastrointestinal InflammationInflammatory Bowel DiseaseInflammatory Disease PharmacotherapyClinical RemissionDurable Clinical ResponseInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease TherapyLoss Of ResponsePlacebo-controlled Efficacy Assessment